Hazlett, Burt & Watson’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Sell
12,900
-112
-0.9% -$18.2K 0.59% 40
2025
Q4
$2.54M Buy
13,012
+222
+2% +$52.9K 0.81% 25
2025
Q3
$3.6M Buy
12,790
+399
+3% +$102K 1.27% 11
2025
Q2
$2.71M Sell
12,391
-124
-1% -$20K 1.11% 13
2025
Q1
$1.75M Sell
12,515
-320
-2% -$52.1K 0.79% 28
2024
Q4
$2.14M Hold
12,835
0.95% 20
2024
Q3
$2.19M Buy
12,835
+1
+0% +$145 1.01% 19
2024
Q2
$1.81M Buy
12,834
+7,601
+145% +$944K 0.93% 22
2024
Q1
$657K Sell
5,233
-23
-0.4% -$2.63K 0.39% 55
2023
Q4
$554K Buy
5,256
+2
+0% +$218 0.37% 54
2023
Q3
$556K Buy
5,254
+1
+0% +$116 0.41% 48
2023
Q2
$627K Buy
5,253
+428
+9% +$44.3K 0.47% 37
2023
Q1
$446K Buy
4,825
+25
+0.5% +$2.19K 0.36% 54
2022
Q4
$392K Sell
4,800
-63
-1% -$4.79K 0.34% 59
2022
Q3
$298K Buy
4,863
+1
+0% +$73 0.29% 73
2022
Q2
$339K Hold
4,862
0.31% 67
2022
Q1
$401K Buy
+4,862
New +$394K 0.32% 64

Other funds holding ORCL

Hazlett, Burt & Watson's ORCL Position: Q1 2026 in Review

Hazlett, Burt & Watson reduced its Oracle (ORCL) stake by 0.86% in Q1 2026, selling an estimated $18.2K and leaving 12,900 shares worth $1.9M. The position accounts for 0.59% of the portfolio, ranked #40.

Hazlett, Burt & Watson first reported a position in ORCL in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.6M in Q3 2025. 3,474 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Hazlett, Burt & Watson held 12,900 shares of Oracle worth $1.9M as of Q1 2026.
  • Hazlett, Burt & Watson sold 112 Oracle shares in Q1 2026, an estimated $18.2K.
  • Oracle made up 0.59% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #40 holding.
  • Hazlett, Burt & Watson first reported a position in Oracle in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's Oracle position peaked at $3.6M in Q3 2025.
  • 3,474 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.